Cargando…
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis
Background and Rationale: Among the key players in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS), microglia and T regulatory lymphocytes (Treg) are candidate cells for modifying the course of the disease. The gut microbiota (GM) acts by shaping immune tolerance and regulating the Treg numb...
Autores principales: | Mandrioli, Jessica, Amedei, Amedeo, Cammarota, Giovanni, Niccolai, Elena, Zucchi, Elisabetta, D'Amico, Roberto, Ricci, Federica, Quaranta, Gianluca, Spanu, Teresa, Masucci, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763586/ https://www.ncbi.nlm.nih.gov/pubmed/31620079 http://dx.doi.org/10.3389/fneur.2019.01021 |
Ejemplares similares
-
Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder
por: Zucchi, Elisabetta, et al.
Publicado: (2019) -
“Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: Quaranta, Gianluca, et al.
Publicado: (2022) -
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis
por: Martinelli, Ilaria, et al.
Publicado: (2022) -
High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial
por: Zucchi, Elisabetta, et al.
Publicado: (2019) -
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
por: Mandrioli, Jessica, et al.
Publicado: (2023)